Plastiblends India Limited Overview
Plastiblends India Limited is one of India's oldest and largest specialist masterbatch producers, manufacturing white, black, colour, additive and filler masterbatches together with polyester masterbatches, conductive compounds and, since 2021, engineering-plastics compounds under the ENGITECH brand. Founded in 1991 by the Kabra family's Kolsite Group (also the promoter of plastics-machinery maker Kabra Extrusiontechnik), the company operates three manufacturing locations at Daman (two units), Roorkee and Palsana (Surat), with roughly 125,000 to 130,000 tonnes per annum of capacity. It exports to more than 60 countries; exports were about 19% of revenue in FY2025 and FY2026. The business is a mid-single-digit-margin converter whose economics are dominated by polymer and pigment input costs. Its distinguishing financial trait is a near debt-free balance sheet with CRISIL A+ rating, but returns on equity have stagnated near 8% as volumes plateaued. Management is repositioning the mix toward black and engineering masterbatches to lift margins.
What the company does
Plastiblends manufactures masterbatches: concentrated, pelletised dispersions of pigments (colourants) and/or functional additives in a polymer carrier resin. Plastic processors (film blowers, injection moulders, raffia/woven-sack makers, fibre spinners, pipe extruders, blow moulders) let down a small dosage of masterbatch into virgin or recycled polymer. This imparts colour, opacity, UV stability, anti-static behaviour, slip, anti-block, flame retardancy, antimicrobial or anti-rodent behaviour and similar properties without the processor having to handle raw pigments or additives. The company also makes compounds: fully formulated thermoplastics such as conductive PE/PP/PS compounds and engineering-plastic compounds based on PA6, PA66, PBT, PC, ABS and PP, including blends and alloys.
The company's own description
The company describes itself as India's leading producer and exporter of colour, white, black, additive and filler masterbatches. It says its products serve the plastics and textile industries, that it operates from a Mumbai headquarters with product-development and application units at Daman (two), Roorkee and Palsana, and that annual capacity exceeds 130,000 MT. It cites ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and Global Recycled Standard (4.0) certification, DSIR recognition of its in-house R&D unit, and NABL accreditation of its Daman laboratory. Exchange press releases consistently describe it as the largest player in the masterbatch segment (Source: plastiblends.com "About Us", accessed Oct 2026; Q2 FY2026 press release, 16 Oct 2025).
Business and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | Almost 100% product sales (B2B industrial intermediates). No subscription, licensing or service revenue disclosed. Minor other operating income (export incentives, scrap). |
| Pricing mechanism | Cost-plus with partial pass-through. Polymer (crude-linked) is 45-50% of raw-material cost. CRISIL notes major raw-material costs are generally passed on, but intense competition prevents full pass-through of escalations (CRISIL, Jun 2026). |
| Order profile | Repeat, short-cycle orders from processors; custom colour matching; no long-term take-or-pay contracts disclosed. |
| Channel | Direct sales to processors and OEM-approved moulders, plus dealers/distributors domestically and in export markets (Directors' Report acknowledges "Customers, Dealers"). |
| Value-chain position | Mid-stream. Upstream suppliers are petrochemical majors (polymers: PE, PP, PET), pigment producers (TiO2, carbon black, organic pigments) and additive houses. Downstream customers are plastic converters, who in turn supply FMCG packaging, agriculture/irrigation, automotive, appliances, textiles, wire and cable, and pipes. |
| Capital intensity | Low-to-moderate. Twin-screw extrusion lines; maintenance plus growth capex of INR 15-20 crore per year guided (CRISIL). |
| Working-capital intensity | High. Cash conversion cycle of 137 days in FY2026 (Screener). Gross current asset days (net of cash) rose to 145 in FY2026 from 125 in FY2025 (CRISIL). |
Customer types and end-markets
The website lists nine application verticals: Agriculture; Appliances; Automotive and Transportation; Electrical, Electronics and Telecommunication; Flexible Packaging; Healthcare and Pharmaceutical; Rigid Packaging; Textiles; and Wire and Cable. Trade coverage adds infrastructure and consumer goods. CRISIL identifies the irrigation segment (drip/sprinkler pipes and laterals, largely black masterbatch) as a source of weak demand in FY2026. It also flags a deliberate shift away from the commoditised "Polywhite" (white masterbatch) segment toward black and engineering masterbatches, which serve automotive and white goods.
Independent characterisation
Plastiblends is best understood as a scale-led, low-margin specialty-commodity converter with a franchise in Indian polyolefin masterbatches (white, black and colour for film, raffia and moulding). Three structural facts define its economics:
-
The value added is a thin slice of a crude-linked bill of materials. Gross margin is about 25%, EBITDA margin (ex-other income) is 6.7-7.0%, and net margin is 4.3-4.7% (FY2024 to FY2026).
-
Volume has been stagnant since FY2023. Revenue moved within INR 768 to 802 crore over FY2023 to FY2026, and CRISIL reports an 8% volume decline in FY2025 offset by 4% realisation gains.
-
Balance-sheet conservatism. The company has had no long-term debt since FY2020, carries INR 47 crore of unencumbered cash (Mar 2026), holds mutual-fund and equity investments, and pays a 20-40% dividend.
The FY2027 inflection (Q1 FY2027 EBITDA margin of 9.92%) is the first evidence in four years that the mix-shift strategy can lift margins. A meaningful contribution from the Q4 FY2026 inventory gain and the low Q1 FY2026 base means it is not yet proven.
Financial Narrative
Sources and definitions.
-
Revenue = revenue from operations as reported. FY2025 and FY2024 are confirmed by the FY2024-25 Directors' Report: INR 78,045.35 lakh and INR 80,216.16 lakh. FY2026 is confirmed by the results filing: INR 78,866 lakh.
-
Gross profit, EBIT, EBITDA (excluding other income), PBT, PAT, EPS and DPS for FY2022–FY2026 are from S&P Global Market Intelligence data via StockAnalysis.com (updated 13 Jul 2026).
-
Balance-sheet and cash-flow lines are from Screener.in (standalone), rounded to INR crore.
-
Note: Screener's "Sales" line (FY2026: 768; FY2025: 758) is lower than reported revenue from operations because of classification differences. Reported revenue is used here.
Income statement
Depreciation for FY2022–FY2026 is per Screener (StockAnalysis "D&A for EBITDA" is 13.1-13.8 because it excludes some amortisation). FY2025 depreciation is confirmed by the Directors' Report at INR 1,522.35 lakh.
Company-defined EBITDA (includes other income; Directors' Report FY2024-25). FY2024: INR 6,272.86 lakh (7.82% margin). FY2025: INR 6,140.86 lakh (7.87%). CRISIL-adjusted operating margin: 6.8% FY2024, 7.4% FY2025, 7.8% FY2026. Readers should note the three different EBITDA definitions in circulation.
Margin profile
Commentary. FY2022's 24% growth was a post-COVID rebound and polymer price inflation, not volume. FY2023 is the trough year: gross margin compressed to 22.5% as high-cost polymer inventory met falling realisations, and PAT fell 27% to INR 26.9 crore. Since FY2024 gross margin has recovered to about 25%, reflecting mix improvement and softer input costs. Revenue, however, has been flat. CRISIL attributes FY2025's 2.7% decline to roughly 8% volume degrowth partly offset by 4% realisation gains. FY2026's 1.1% growth came from about 2% realisation gains against moderating volumes, owing to weak irrigation demand and the deliberate exit from Polywhite.
The FY2026 operating margin uplift to 7.8% (CRISIL basis) was flattered by a one-time inventory gain in Q4 FY2026, when polymer prices spiked amid the West Asia crisis. Other income has risen materially, from INR 6 crore in FY2022 to INR 13 crore in FY2026 (Screener), driven by treasury income, FX gains (INR 4.7 crore in FY2026) and investment gains. It now contributes about a quarter of PBT, an earnings-quality consideration.
Quarterly trajectory (last 9 quarters)
Sources: exchange results filings and press releases (Q2 FY2026 PR 16 Oct 2025; Q3 FY2026 filing 14 Jan 2026; Q4 FY2026 filing 27 Apr 2026; Q1 FY2027 filing 13 Jul 2026). Q1 and Q3 FY2025 revenue are derived from H1/FY totals.
Q1 FY2027 detail: revenue +11.0% YoY; total expenses INR 203.75 crore (vs INR 190.26 crore); PBT INR 20.23 crore (+70.1%); PAT INR 14.95 crore (+67.5%); EBITDA margin 9.92% vs 6.75%. Raw-material cost was INR 162.40 crore (vs INR 145.62 crore). TTM to June 2026: revenue approx. INR 810.6 crore; PAT approx. INR 42.7 crore; EPS approx. INR 16.43.
Balance sheet (31 March; INR crore; Screener standalone)
Supplementary balance-sheet items (partial disclosure):
Investments include the 2.37% stake in Kabra Extrusiontechnik, carried at fair value through OCI. The FY2024 OCI loss of INR 1,371.85 lakh likely reflects the mark-to-market decline in that holding; this attribution is an analyst inference, not stated in the extract.
Balance-sheet commentary. Equity has compounded at about 4% a year since FY2022, constrained by modest ROE and dividends. Borrowings fell from INR 45 crore (FY2022) to INR 5 crore (FY2025) before rising to INR 22 crore in FY2026. That increase funded deliberate inventory building ahead of crude-linked raw-material spikes and supply-continuity concerns during the West Asia crisis (CRISIL Jun 2026). Other assets grew INR 39 crore in FY2026, mostly inventory and receivables, the main source of the cash-flow weakness described below.
Cash flow (INR crore; Screener)
Capex is derived as CFO less FCF. Dividends paid are derived as the prior-year DPS times 2.5989 crore shares. FY2025 is confirmed at INR 1,104.54 lakh and FY2026 at INR 649.73 lakh by the Directors' Report.
Commentary. Cash conversion is volatile and has deteriorated. Cumulative FCF over FY2025–FY2026 was negative (INR -8 crore) despite INR 70 crore of PAT, because working capital absorbed cash: debtor days rose from 41 to 62 and inventory days from 76 to 96 between FY2024 and FY2026. FY2023's exceptional INR 72 crore CFO reflected inventory liquidation in a falling polymer-price environment. The dividend cut in FY2025 (to INR 2.50 from INR 4.25) was explicitly linked to conserving liquidity for capex amid tariff and geopolitical uncertainty (Directors' Report FY2025).
Ratios
Ratio commentary. The company earns a sub-cost-of-capital ROE (about 8%) on an over-capitalised balance sheet. The constraint is margin, not leverage or turnover: asset turnover of about 1.5x is respectable for a converter, but a 4-5% net margin caps ROA near 7%. The historical comparison is stark. ROCE was 27% in FY2015 and 25% in FY2016 (Screener) when OPM was 10-12%. The single most important variable for equity value is therefore whether the mix shift can restore EBITDA margins toward the 9-12% range. CRISIL's upgrade trigger is a sustained 11-12% operating margin.
7. SEGMENTAL AND GEOGRAPHIC REVENUE MAPPING
Segment × geography
The company reports only one segment.
Geographic revenue (INR crore; derived from CRISIL export-share disclosures applied to reported revenue):
FY2024 export share is NPD in verifiable form. Growth rates: exports approx. +1.1% in FY2026, domestic approx. +1.0% in FY2026.
Geographic footprint of sales
Country-level revenue is NPD.
Fastest-growing and declining regions
Exports declined as a share of revenue from about 22% to 19% by FY2025 and stayed flat in FY2026. Management's FY2025 report noted that the company "regained market share" in export markets during the year. However, the export share did not recover, which suggests price competition (notably from Chinese and Southeast Asian masterbatch producers) and freight/geopolitical disruptions. Domestic demand was hit by two factors flagged in the FY2025 Directors' Report: an urban consumption slowdown, and a cutback in government capex and infrastructure spending after the 2024 national and state elections. The irrigation sub-market was weak in FY2026 (CRISIL). The Q1 FY2027 recovery (+11% YoY) was attributed by commentary to healthy domestic demand in industrial packaging and consumer polymer masterbatches (EquityBulls, 13 Jul 2026). No region-level growth data has been published.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 717.6 | 768.5 | 802.2 | 780.5 | 788.7 |
Revenue growth YoY (%) | 24.3 | 7.1 | 4.4 | -2.7 | 1.1 |
Gross profit (INR Cr) | 175.7 | 173.1 | 193.7 | 196.3 | 198.3 |
Operating income / EBIT (INR Cr) | 46.8 | 34.0 | 40.6 | 39.1 | 42.0 |
EBITDA excl. other income (INR Cr) | 59.9 | 47.9 | 53.8 | 52.1 | 54.9 |
Depreciation and amortisation (INR Cr) | 16.0 | 16.0 | 15.4 | 15.2 | 15.0 |
Interest expense (INR Cr) | 3.1 | 2.1 | 1.3 | 1.3 | 2.1 |
Profit before tax (INR Cr) | 49.0 | 36.5 | 46.2 | 44.9 | 48.8 |
Tax expense (INR Cr) | 12.3 | 9.6 | 11.6 | 11.5 | 12.1 |
Net income / PAT (INR Cr) | 36.7 | 26.9 | 34.5 | 33.4 | 36.7 |
EPS basic (INR) | 14.12 | 10.33 | 13.28 | 12.87 | 14.12 |
EPS diluted (INR) | 14.12 | 10.33 | 13.28 | 12.87 | 14.12 |
Dividend per share (INR) | 4.00 | 4.00 | 4.25 | 2.50 | 3.00 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 24.5 | 22.5 | 24.2 | 25.2 | 25.1 |
EBITDA margin excl. other income (%) | 8.4 | 6.2 | 6.7 | 6.7 | 7.0 |
EBIT / operating margin (%) | 6.5 | 4.4 | 5.1 | 5.0 | 5.3 |
PBT margin (%) | 6.8 | 4.7 | 5.8 | 5.8 | 6.2 |
Net margin (%) | 5.1 | 3.5 | 4.3 | 4.3 | 4.7 |
Effective tax rate (%) | 25.1 | 26.4 | 25.2 | 25.6 | 24.8 |
CAGR by Period
| Period | CAGR |
|---|---|
FY2021–FY2026 (5-year; FY2021 base approx. INR 577.3 crore per TipRanks/S&P) | approx. 6.4% |
FY2022–FY2026 (4-year) | approx. 2.4% |
FY2023–FY2026 (3-year) | approx. 0.9% |
Screener 10-year sales CAGR | 4% |
Screener 5-year sales CAGR | 7% |
Screener 3-year sales CAGR | 1% |
Income Statement and Per-Share Data
| Metric | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 211.6 | 185.4 | 184.4 | 199.2 | 199.6 | 192.6 | 185.8 | 210.6 | 221.6 |
PAT (INR Cr) | 10.8 | 6.3 | 6.7 | 9.6 | 8.9 | 7.4 | 6.5 | 13.9 | 15.0 |
EPS (INR) | 4.17 | 2.43 | 2.58 | 3.68 | 3.43 | 2.86 | 2.49 | 5.33 | 5.75 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 518 | 484 | 482 | 507 | 558 |
Net fixed assets (INR Cr) | 189 | 181 | 176 | 170 | 180 |
Capital work in progress (INR Cr) | 2 | 0 | 1 | 3 | 6 |
Investments (INR Cr) | 51 | 67 | 71 | 56 | 56 |
Other assets incl. current assets (INR Cr) | 275 | 236 | 235 | 277 | 316 |
Total borrowings (INR Cr) | 45 | 9 | 8 | 5 | 22 |
Other liabilities (INR Cr) | 92 | 81 | 69 | 75 | 86 |
Share capital (INR Cr) | 13 | 13 | 13 | 13 | 13 |
Reserves (INR Cr) | 368 | 382 | 392 | 415 | 436 |
Shareholders' equity (INR Cr) | 381 | 395 | 405 | 428 | 449 |
Book value per share (INR) | 146.6 | 152.0 | 155.8 | 164.7 | 172.8 |
Financial Analysis
| Item | Value | Source |
|---|---|---|
Unencumbered cash surplus, 31 Mar 2026 | INR 47 crore | CRISIL Jun 2026 |
Unencumbered cash surplus, 31 Mar 2025 | INR 38 crore | CRISIL Jul 2025 |
Mutual-fund investments, 31 Mar 2025 | approx. INR 32.28 crore | Directors' Report FY2025 |
Net debt, 31 Mar 2026 | approx. INR -25 crore (net cash) | Computed: borrowings 22 less cash 47 |
Net debt, 31 Mar 2025 | approx. INR -33 crore (net cash) | Computed: borrowings 5 less cash 38 |
Long-term debt | Nil since FY2020; all borrowings are working-capital lines | CRISIL Jun 2026 |
Fund-based limits | INR 94 crore, approx. 21% average utilisation in the six months to Mar 2026; lenders Citibank N.A., HSBC, HDFC Bank, Kotak Mahindra Bank | CRISIL Jun 2026 |
Goodwill and intangibles | Negligible / NPD (no acquisitions) | — |
Total outside liabilities / adjusted net worth | 0.24x (Mar 2026) | CRISIL Jun 2026 |
Working capital (current assets less current liabilities) | NPD in machine-readable form | — |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operations (INR Cr) | 15 | 72 | 38 | 9 | 21 |
Capital expenditure (INR Cr) | 5 | 8 | 12 | 11 | 27 |
Free cash flow (INR Cr) | 10 | 64 | 26 | -2 | -6 |
Cash from investing (INR Cr) | -5 | -26 | -27 | 6 | -33 |
Cash from financing (INR Cr) | -12 | -45 | -11 | -12 | -8 |
Dividends paid (INR Cr) | 10.4 | 10.4 | 10.4 | 11.0 | 6.5 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
CFO / operating profit (%) | 44 | 166 | 91 | 40 | 61 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Return on average equity (%) | 10.3 | 6.9 | 8.6 | 8.0 | 8.4 |
Return on average assets (%) | 7.6 | 5.4 | 7.1 | 6.8 | 6.9 |
ROCE, Screener (%) | 13 | 9 | 11 | 10 | 11 |
ROIC, computed: NOPAT / (equity + debt) (%) | 8.2 | 6.2 | 7.4 | 6.7 | 6.7 |
Debt to equity (x) | 0.12 | 0.02 | 0.02 | 0.01 | 0.05 |
Interest coverage, EBIT / interest (x) | 15.1 | 16.1 | 30.4 | 30.9 | 19.6 |
Asset turnover, revenue / average assets (x) | 1.48 | 1.53 | 1.66 | 1.58 | 1.48 |
Debtor days | 62 | 44 | 41 | 54 | 62 |
Inventory days | 93 | 76 | 76 | 88 | 96 |
Payable days | 16 | 17 | 14 | 18 | 21 |
Cash conversion cycle (days) | 139 | 102 | 104 | 124 | 137 |
Dividend payout (%) | 28 | 39 | 32 | 19 | 21 |
Financial Analysis — Net debt / EBITDA, FY2026
| Ratio | Value | Source / note |
|---|---|---|
Net debt / EBITDA, FY2026 | approx. -0.5x (net cash) | Computed |
Net debt / EBITDA, FY2025 | approx. -0.6x (net cash) | Computed |
CRISIL-adjusted interest coverage | 48.58x FY2025; 30.82x FY2026 | CRISIL Jun 2026 |
CRISIL-adjusted debt / net worth | 0.00x FY2025; 0.04x FY2026 | CRISIL Jun 2026 |
Current ratio | NPD in machine-readable form; qualitatively strong given 0.24x TOL/ANW | — |
Screener 10-year average ROE | 10% | Screener |
Income Statement and Margin Analysis (%) (FY2025–FY2026)
| Region | FY2025 | FY2026 |
|---|---|---|
Export revenue, approx. (INR Cr) | 148.3 | 149.9 |
Domestic India revenue, approx. (INR Cr) | 632.2 | 638.8 |
Export share (%) | 19 | 19 |
Region Overview
| Region | Evidence | Source |
|---|---|---|
India (domestic) | approx. 81% of revenue; strongest in western India (Gujarat, Maharashtra) and north (Roorkee serves north India) | CRISIL; plant locations |
Asia (incl. Southeast Asia, Middle East) | Moderate export presence; management targeting Southeast Asian penetration to rebuild export share | CRISIL Jul 2025, Jun 2026 |
Africa | Moderate export presence | CRISIL |
Latin America | Moderate export presence | CRISIL |
Europe, North America | Cited on the company website as markets reached | Company website |
Total country reach | Exports to 60+ countries | Company website; Modern Plastics India |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Price (7 Oct 2026) | approx. INR 205 (NSE) | IIFL |
Price (5 Oct 2026 close) | INR 198 | Screener |
52-week high / low | INR 216 / 121 | Screener |
1-year price CAGR | +7% | Screener |
3-year price CAGR | -5% | Screener |
5-year price CAGR | -7% | Screener |
10-year price CAGR | -1% | Screener |
Beta | 1.28 | Sharpely |
Reference points | INR 183.83 (13 Mar 2025); INR 161.64 (19 Dec 2025); INR 172.02 (29 May 2026); approx. INR 206 (14 Jul 2026) | ICICI Direct; IIFL; Univest |
Valuation Snapshot by Multiple
| Multiple | Value | Basis |
|---|---|---|
Market cap | approx. INR 533 crore | 2.5989 crore shares × INR 205.09 |
P/E (TTM, EPS INR 16.43) | approx. 12.5x | TTM Jun 2026 |
P/E (FY2026, EPS INR 14.12) | approx. 14.5x | FY2026 |
P/B (BVPS approx. INR 173) | approx. 1.19x | Mar 2026 book |
EV (market cap + debt 22 − cash 47) | approx. INR 508 crore | Mar 2026 balance sheet |
EV / EBITDA (TTM approx. INR 62.2 crore) | approx. 8.2x | S&P TTM EBITDA |
EV / Sales (TTM approx. INR 810.6 crore) | approx. 0.63x | TTM |
Dividend yield (INR 3.00) | approx. 1.5% | FY2026 DPS |
Screener-quoted P/E (5 Oct 2026) | 12.0x | Screener |
Per-Share Data and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 4.00 | 4.00 | 4.25 | 2.50 | 3.00 |
Dividend as % of face value (%) | 80 | 80 | 85 | 50 | 60 |
Payout ratio (%) | 28 | 39 | 32 | 19 | 21 |
Total cash outflow (INR Cr) | 10.4 | 10.4 | 11.0 | 6.5 | 7.8 |
Capital Markets
| Item | Detail |
|---|---|
Buybacks | None authorised or executed in the last 10 years |
Equity actions | Share split INR 10 → INR 5 (Feb 2012); 1:1 bonus (Jul 2017). No dilution since |
Credit ratings | CRISIL A+/Stable (LT) and CRISIL A1 (ST), reaffirmed 11 Jun 2026, consistent since at least 2023. No Moody's, S&P or Fitch ratings (not applicable for an Indian micro-cap) |
Debt maturity profile | No term debt. Working-capital facilities of INR 96 crore (fund-based INR 90 crore, non-fund-based INR 6 crore) are annually renewable; outstanding borrowings were INR 22 crore at 31 Mar 2026, all short-term |
Date / Period Details
| Date / period | Catalyst | What to watch |
|---|---|---|
12 Oct 2026 | Q2 FY2027 results | Whether the EBITDA margin holds above 8.5% without inventory gains; volume vs. realisation commentary |
H2 FY2027 | ENGITECH Palsana ramp-up | Commissioning confirmation, utilisation, new OEM wins |
FY2027 | Solar build-out | Progress toward 6 MW; power-cost savings per tonne |
Quarterly | Working capital | Inventory and receivable days trending back toward FY2024 levels (76/41) |
Quarterly | Export share | Movement from 19% toward 22% (Southeast Asia penetration) |
Ongoing | Promoter consolidation | Completion of the 8.85% transfer; any change in the KET cross-holding |
Ongoing | Polymer and crude prices | Effect on inventory gains/losses |
Apr–May 2027 | FY2027 results and dividend | Payout restoration toward 30%+ |
Mid-2027 | CRISIL review | Outlook revision (upgrade trigger: 11-12% margin) |
Executive Leadership
Board of Directors
| Name | Designation | Tenure / appointment | Education | Background | Age |
|---|---|---|---|---|---|
Satyanarayan G. Kabra | Chairman and Managing Director (DIN 00015930) | Co-founder; designated CEO/MD since Aug 2018 per Simply Wall St; promoter since 1991 | B.E. (Mechanical), Mumbai University; Honorary Doctorate, European International University, Paris | Co-founder of the Kolsite Group; co-founder and former MD of Kabra Extrusiontechnik (from 1 Jul 2008) | approx. 81 (80 per Simply Wall St, May 2025) |
Varun S. Kabra | Vice-Chairman and Managing Director (DIN 03376617) | Reappointed for 5 years by the board on 27 Apr 2026; approved at the 35th AGM, 24 Aug 2026 | B.E.; M.S. Industrial and Operations Engineering, University of Michigan, Ann Arbor | Strategic management, sales and marketing, materials management, lean manufacturing | NPD |
Jyoti V. Kabra | Non-Executive, Non-Independent Director | Retired by rotation and reappointed at the 34th AGM (2025) | B.Com; MBA (Marketing); Diploma in Advertising | Marketing and brand communication; promoter-group shareholder | NPD |
Rahul R. Rathi | Independent Director | NV | Master's, Carnegie Mellon University; Polymer Engineering, University of Pune | 20+ years in equity research and risk analytics (New York, London, Asia); associated with Purnartha investment philosophy; partner, Beharay Rathi Group; Chairman, Rathi Techservices | NPD |
Meena S. Agrawal | Independent Director | First term from 29th AGM (30 Sep 2020); second 5-year term from 29 Jun 2025 | B.Com, Mumbai University | 25+ years with social organisations; Director, Nandan Group | NPD |
Dharmendra K. Gandhi | Independent Director | From 1 Jul 2024 | NPD | MD, Mutual Automotive Pvt Ltd; co-founder, Mutual Group; President of OPPI 2018-20; Treasurer, Plastindia Foundation; 40+ years in the polymer industry | NPD |
Surendra S. Gupta | Independent Director | Additional Director from 28 Apr 2025; regularised at the 34th AGM | CA, CMA, CS, B.Com | Author on GST law; faculty at ICAI, ICWAI, IMC; social-sector leadership | NPD |
Governance Detail
| Role | Name | Note |
|---|---|---|
CEO / Managing Director | Satyanarayan G. Kabra (CMD) and Varun S. Kabra (VC and MD) | Dual MDs |
Chief Financial Officer | Name NV (Simply Wall St indicates a CFO tenure of about 9.8 years) | — |
Company Secretary and Compliance Officer | Himanshu Mhatre (signatory on 2019-2020 filings; aggregator shows a CS tenure of about 14 years); current incumbency NV | — |
AVP – Engineering Plastics | Prashant Pandya | Modern Plastics India, Dec 2024 |
Executive Leadership Team
| Executive | Total remuneration | Composition | Source |
|---|---|---|---|
Satyanarayan G. Kabra (CMD) | INR 1.363 crore (INR 13.63 million) | approx. 60.5% salary, 39.5% bonus/other | Simply Wall St (latest FY available, c. FY2025) |
Varun S. Kabra (VC and MD) | NPD in accessible extract | — | — |
Non-executive directors | Sitting fees; amounts NPD in accessible extract | — | — |
Board & Management Changes
| Date | Change |
|---|---|
1 Jul 2024 | Dharmendra K. Gandhi appointed Independent Director |
28 Apr 2025 | Surendra S. Gupta appointed Additional (Independent) Director |
29 Jun 2025 | Meena S. Agrawal begins second term as Independent Director |
27 Apr 2026 / 24 Aug 2026 | Varun S. Kabra reappointed VC and MD for 5 years |
Shareholding Trend
| Holder category | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Promoters and promoter group (%) | 64.38 | 63.08 | 62.82 | 62.82 | 62.07 |
Foreign institutions (%) | 0.65 | 0.69 | 0.24 | 0.24 | 0.26 |
Domestic institutions (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public / retail (%) | 34.97 | 36.24 | 36.94 | 36.95 | 37.68 |
Number of shareholders | 17,494 | 16,655 | 17,808 | 17,034 | 18,534 |
Major Shareholders
| Holder | Stake | Source / date |
|---|---|---|
Varun Satyanarayan Kabra | 34.81% post-transfer (from 30.38%) | FilingReader, 30 Jul 2026 (proposed inter-se) |
Jyoti Varun Kabra | 11.22% post-transfer (from 6.79%) | FilingReader, 30 Jul 2026 |
Kabra Extrusiontechnik Ltd | 5.35% (as of 30 May 2025; later status NV) | Screener announcement |
Satyanarayan Gopilal Kabra | approx. 2.6% | Simply Wall St (2025) |
Saritadevi Satyanarayan Kabra | Promoter group; stake NV | ScanX (Jun 2026 filing) |
Kolsite Corporation LLP | 0.01% post-transfer (from 8.86%) | FilingReader, 30 Jul 2026 |
Anand Shreevallabh Kabra | 4,000 shares (0.02%) | ScanX (Jun 2026 filing) |
Targets & Commitments
| Initiative | Date | Description | Targets / status |
|---|---|---|---|
ENGITECH Palsana capacity expansion | Groundbreaking 7 Dec 2024 | New plant doubling engineering-compound capacity | 12 KTPA; scalable to 24 KTPA; volume offtake ramping in FY2027 (CRISIL) |
Solar augmentation | FY2025–FY2027 | Rooftop solar at all units, expanding to 6 MW | INR 15-20 crore capex in FY2027 |
Liquidity conservation | Apr 2025 | Dividend cut to INR 2.50 to fund capex and buffer tariff/geopolitical risk | Dividend raised to INR 3.00 in Apr 2026 |
Strategic inventory build | FY2026 (Q4) | Raw-material stocking for supply continuity during the West Asia crisis | Raised GCA days to 145; produced a one-time inventory gain |
Polywhite de-emphasis | FY2026 onwards | Gradual exit from low-margin white masterbatch volume | Ongoing |
Southeast Asia export push | FY2025 onwards | Market development | Export share flat at 19% so far |
Promoter succession / consolidation | Jun–Jul 2026 | Transfer of Kolsite LLP holdings to Varun and Jyoti Kabra (Varun to 34.81%) | Completes generational transition of direct ownership |
Governance Overview
| Item | CRISIL expectation |
|---|---|
FY2027 revenue growth | approx. 9% (black masterbatch demand and engineering masterbatch offtake) |
Medium-term operating margin | 7-7.5% |
Annual capex | INR 15-20 crore |
Annual net cash accruals | INR 45-50 crore |
Interest coverage | Above 32x |
TOL/ANW | Below 0.24x |
Upgrade trigger | Substantial scale-up with sustained 11-12% operating margin |
Downgrade trigger | Sustained operating margin below 7%, or debt-funded capex / working-capital stretch |
Competitive Landscape
Key Competitors
| Competitor | Ownership / listing | Segments competing | Relative positioning vs Plastiblends | Revenue |
|---|---|---|---|---|
Avient Corporation (incl. former Clariant Masterbatches, acquired 2020) | NYSE: AVNT (US) | Colour, additive, engineering compounds | Global technology and brand leader; strong with MNC FMCG/packaging and automotive accounts in India | Global approx. |
Cabot Corporation / Cabot India Ltd | NYSE: CBT parent; Indian subsidiary unlisted | Black masterbatch (carbon black integrated) | Backward-integrated in carbon black; strong in black masterbatch for pipes/films | Global approx. |
Ampacet Speciality Products Pvt Ltd | Private (US parent Ampacet Corp.) | Colour, white, additive | Global specialist with Indian manufacturing | NPD |
Alok Masterbatches Pvt Ltd | Private (India) | White, black, colour, additive, filler | Closest domestic full-line rival; strong in north India | NPD |
Tosaf Compounds | Private (Israel; Indian presence) | Additive, colour, compounds | Specialist additives | NPD |
Polmann India Ltd | Indian | Colour, white, additive masterbatch | Domestic mid-size | NPD |
Orbit Masterbatches Pvt Ltd | Private | General masterbatches | Domestic mid-size | NPD |
JJ Plastalloy Pvt Ltd | Private | Masterbatches and compounds | Domestic mid-size | NPD |
Kingfa Science & Technology (India) Ltd | Listed (India; Chinese parent) | Engineering-plastics compounds (vs ENGITECH) | Established automotive compounder | NV |
Envalior, SABIC, BASF (engineering-plastics compounding) | MNCs | Engineering compounds | Polymer-integrated incumbents | NPD for India |
Unorganised regional masterbatch makers | Numerous small units | White, black, filler | About 35% of the market; price-led | — |
Peer Comparison FY2026
| Metric | Plastiblends (FY2026) | Avient (CY2024) | Cabot (FY2024) | Kingfa India |
|---|---|---|---|---|
Revenue | INR 788.7 crore (approx. USD 92 mn) | approx. USD 3.2 bn (NV) | approx. USD 4.0 bn (NV) | NV |
Revenue growth | 1.1% | approx. flat (NV) | approx. flat (NV) | NV |
EBITDA margin | 7.0% (ex-other income) | mid-teens adjusted (NV) | high-teens (NV) | NV |
Net margin | 4.7% | NV | NV | NV |
R&D intensity | NPD | approx. 2-3% (NV) | NV | NV |



